Molecular Health vs Onco Access
Molecular Health vs Onco Access, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Molecular Health is on 54/100 and Onco Access on 15/100.
Where each one leads
Molecular Health
- our overall score: 54/100 against 15/100
Onco Access
- agent readiness: 26/100 against 21/100
At a glance
| Measure | Molecular Health | Onco Access |
|---|---|---|
| What it is | Data-driven software solutions for precision medicine and pharmaceutical development. | OncoAccess provides a platform for oncology clinical trial matching and patient access. |
| Category | HealthTech, Biotech, Genomics, Drug Discovery | HealthTech, MedTech, Clinical Trials, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2004 | 2023 |
| Headquarters | Heidelberg, Germany | New York, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Molecular Health | Onco Access |
|---|---|---|
| Employees | 75 | Not published |
| Total funding | $26.8M | Not published |
| Latest round | PE | Grant |
| LinkedIn followers | 11,421 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Molecular Health | Onco Access |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 54/100 | 15/100 |
| Traction | 56/100 | Not published |
| Team | 70/100 | 30/100 |
| Search visibility | 23/100 | 5/100 |
| Quality | 58/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (26/100) |
| Domain ratingLink authority, 0-100 | 34/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Molecular Health | Onco Access |
|---|---|---|
| Hosting | Self Managed | AWS |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Segment | Not detected |
| Support stack | HubSpot | Not detected |
Molecular Health vs Onco Access: common questions
Which is better, Molecular Health or Onco Access?
On our 0-100 score Molecular Health rates higher (54/100 against 15/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Molecular Health and Onco Access compare on the numbers?
Molecular Health leads on our overall score (54/100 against 15/100). Onco Access leads on agent readiness (26/100 against 21/100).
Read the full Molecular Health review and pricing or the Onco Access review and pricing. You can also browse other Molecular Health alternatives we track.